BCR-ABL kinase domain mutations on second line dasatinib or nilotinib therapy in chronic myeloid leukemia patients after imatinib failure : a cooperative evaluation of different detection methods
暂无分享,去创建一个
Martin C. Müller | D. Niederwieser | K. Porkka | I. Mikkola | A. Hochhaus | T. Ernst | T. Lange | F. Gruber | M. Pfirrmann | O. Pelz-Ackermann | J. Maier